LINC00511 and breast cancer: For BC patients, there is a reciprocal expression pattern between LINC00511 and its downstream miR-185-3p (p = 0.0002; Figure 1A), in which LINC00511 high serum expression levels are associated with low miR-185-3p expression level, as shown in Figures 2B, F, H.